Search
for
Sort by
Research 211–240 of 1000+
- Baricitinib as a treatment for myasthenia gravis: A case report
- Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Causes and therapeutic limitations of clinical alopecia and the advent of human pluripotent stem cell follicular transplantation
- Exosomes: A Promising Strategy for Repair, Regeneration and Treatment of Skin Disorders
- Development and Evaluation of a Niosome-Integrated Microneedle System for Targeted Follicular Delivery of Ketoconazole in Alopecia Therapy
- Convergent Regenerative Strategies in PM&R for Musculoskeletal and Hair Restoration: Integration of PRP, Exosomes, and Physical Modalities
- Pyroptosis in Alopecia Areata: Synthesizing Emerging Hypotheses and Charting a Path to New Therapies
- Role of Topical Ketoconazole in Therapeutic Hair Care Beyond Seborrhoeic Dermatitis and Dandruff
- Platelet-Rich Plasma Contains High Concentrations of DKK1, A Potent Inhibitor of Wnt Signaling that Limits Bone Regeneration and Hair Growth
- II Nanosciesce and Nanotecnology Biomedicals Symposium - Proceedings
- Modulation of Hair Growth Promoting Effect by Natural Products
- JAK-STAT1 as therapeutic target for EGFR deficiency-associated inflammation and scarring alopecia
- ESGCT and FSGT Collaborative Congress Helsinki, Finland September 17–20, 2015 Abstracts
- Current Protocols: Alopecia Areata Mouse Models for Drug Efficacy and Mechanism Studies
- Chemistry, Pharmacology and Therapeutic Potential of Decursin: A Promising Natural Lead for New Drug Discovery and Development
- New 5?-reductase inhibitors: In vitro and in vivo effects
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- KY19382, a novel activator of Wnt/β‐catenin signalling, promotes hair regrowth and hair follicle neogenesis
- The Future of Alopecia Treatment: Plant Extracts, Nanocarriers, and 3D Bioprinting in Focus
- Evaluating the Metabolomic Profile and Anti-Pathogenic Properties of Cannabis Species
- Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf
- Subcutaneous injection of genetically engineered exosomes for androgenic alopecia treatment
- Pathogenic Mechanisms and Mechanism‐Directed Therapies for Androgenetic Alopecia: Current Understanding and Future Directions
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Tissue engineering of human hair follicles using a biomimetic developmental approach
- Divergent proliferation patterns of distinct human hair follicle epithelial progenitor niches in situ and their differential responsiveness to prostaglandin D2
- Hair Follicle Targeting with Nanoparticles
- Catechins-rich tea extract and its functional properties mitigating hair loss
- Alopecia areata susceptibility variant in MHC region impacts expressions of genes contributing to hair keratinization and is involved in hair loss